Gilead Sciences
GILD
#98
Rank
NZ$300.87 B
Marketcap
NZ$242.41
Share price
2.22%
Change (1 day)
24.49%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.73

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$11.91. In 2024 the company made an earnings per share (EPS) of NZ$0.66 a decrease over its 2023 EPS that were of NZ$7.91.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.731674.69%
2024NZ$0.66-91.65%
2023NZ$7.9123.98%
2022NZ$6.38-25.86%
2021NZ$8.614850%
2020NZ$0.17-97.64%
2019NZ$7.370.9%
2018NZ$7.3118.71%
2017NZ$6.16-64.88%
2016NZ$17.53-18.45%
2015NZ$21.5055.28%
2014NZ$13.84296.02%
2013NZ$3.5017.89%
2012NZ$2.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.37 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.37-80.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.16-65.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$40.05 236.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.92 109.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$15.36 28.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$9.53-20.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$26.91 125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.71 6.72%๐Ÿ‡บ๐Ÿ‡ธ USA